Sanofi pumps $554M into new vaccine manufacturing facility in eastern France

The coronavirus pandemic has shown just how much time, effort and cash are required to scale up for new vaccine production. Sanofi is trying to get a head start on that for the next pandemic—and supply its current vaccines at the same time.

Sanofi will spend $554 million to build a "state-of-the-art" vaccine manufacturing facility at Neuville sur Saône directly to the north of Lyons, the French drugmaker said in a release.